ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.877,84
-1,16%
S&P 500
5.064,59
-1,01%
US Dollar vs BRL
5,186
1,32%
Bitcoin
60.233,98
-5,65%
Brent Oil
86,015
-1,46%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Auris Medical Holding AG (EARS)

  7. Auris Medical Holding AG (EARS) Notícias

EARS

Auris Medical (EARS)

Auris Medical Holding AG
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EARS
DataHoraFonteTítuloCódigoCompanhia
27/06/202317:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
16/06/202318:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
12/06/202307:44Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
09/06/202317:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
27/04/202317:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
17/04/202313:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:EARSAuris Medical Holding AG
13/04/202309:20Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:EARSAuris Medical Holding AG
11/04/202317:02Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:EARSAuris Medical Holding AG
11/04/202317:02Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
27/03/202311:34Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
23/09/202217:32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:EARSAuris Medical Holding AG
14/04/202217:53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:EARSAuris Medical Holding AG
12/04/202209:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:EARSAuris Medical Holding AG
08/12/202118:38Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EARSAuris Medical Holding AG
16/07/202110:00GlobeNewswire Inc.Auris Medical Announces Launch of New Corporate WebsiteNASDAQ:EARSAuris Medical Holding AG
14/07/202110:00GlobeNewswire Inc.Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation...NASDAQ:EARSAuris Medical Holding AG
06/07/202110:00GlobeNewswire Inc.Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™...NASDAQ:EARSAuris Medical Holding AG
28/06/202109:30GlobeNewswire Inc.Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in GermanyNASDAQ:EARSAuris Medical Holding AG
21/06/202109:30GlobeNewswire Inc.Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adul...NASDAQ:EARSAuris Medical Holding AG
03/06/202108:30GlobeNewswire Inc.Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic RepositioningNASDAQ:EARSAuris Medical Holding AG
01/06/202109:30GlobeNewswire Inc.Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in IndiaNASDAQ:EARSAuris Medical Holding AG
28/05/202109:30GlobeNewswire Inc.Auris Medical Holding to Present at LD Micro Invitational XI ConferenceNASDAQ:EARSAuris Medical Holding AG
25/05/202110:00GlobeNewswire Inc.Auris Medical Announces Completion of Bentrio Conformity Assessment Procedure for Marketing in EUNASDAQ:EARSAuris Medical Holding AG
14/05/202109:30GlobeNewswire Inc.Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral VertigoNASDAQ:EARSAuris Medical Holding AG
07/05/202110:05GlobeNewswire Inc.Auris Medical Provides Update on Bentrio Program in AllergyNASDAQ:EARSAuris Medical Holding AG
13/04/202108:45GlobeNewswire Inc.Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market LaunchNASDAQ:EARSAuris Medical Holding AG
08/04/202109:00GlobeNewswire Inc.Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021NASDAQ:EARSAuris Medical Holding AG
31/03/202109:30GlobeNewswire Inc.Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial ResultsNASDAQ:EARSAuris Medical Holding AG
24/03/202109:00GlobeNewswire Inc.Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, ...NASDAQ:EARSAuris Medical Holding AG
29/01/202110:30GlobeNewswire Inc.Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic RhinitisNASDAQ:EARSAuris Medical Holding AG
 Apresentando as notícias mais relevantes sobre:NASDAQ:EARS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
EMAE4
EMAE PN
BOV
TECN3
TECHNOS ON
BOV
OIBR3
OI ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
HAGA3
HAGA ON
BOV
RCSL4
RECRUSUL PN
BOV
POSI3
POSITIVO TEC ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
CIEL3
CIELO ON
BOV
AZEV3
AZEVEDO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados